Charles River Laboratories expanding Memphis CDMO biotech facility Memphis Business Journal

Charles River Labs says its biotech, pharma clients' data was hacked Boston Business Journal

Charles River Laboratories agreed to throw down $875 million cash for Cognate in a deal designed to create a one-stop-shop in cell and gene therapies. Cognate's production muscle will complement.

On the front lines of Parkinson’s research Fierce Biotech

Charles River Laboratories International, Inc. (NYSE:CRL) agreed to acquire 80% stake in Hainan New Source Biotech Co., Ltd. on August 1, 2019. Qiang Li and Stewart Wang of DLA Piper acted as legal advisors to Charles River Laboratories International, Inc. Charles River Laboratories International, Inc. (NYSE:CRL) completed the acquisition of 80.

Charles River Laboratories spends 295M on Explora Biolabs to boost preclinical models biz

Biologics Testing Solutions QC Microbial Solutions Scientific and Regulatory Advisory Services Vivarium Rental & Staffing Services By Molecule Type Cell & Gene Therapy Preclinical Testing Manufacturing & Commercialization BY Therapeutic Area Infectious Disease Microbiome Research Musculoskeletal Disease Ophthalmology

Charles River Laboratories Event on February 1, 2023 Buckeye Biotechnology

Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.

Dogma Therapeutics' collaboration with Charles River and Viva Biotech has resulted in a

Charles River Biotech Symposium Since its' inception 27 years ago, the Biotech Symposium has been the ideal open forum for industry experts to share their successes and challenges, while networking and sharing best practices with colleagues.

Charles River in Reno big part of biotech industry boom Serving Northern Nevada

• Founded: 1947 • Headquarters: Wilmington, MA • Employees: 14,700+ worldwide • Revenue: $2.27 billion in FY2018 • Ownership: Publicly traded (CRL) • Customers: Leading pharmaceutical, biotechnology, agrochemical, government and academic organizations around the world

Charles River Laboratories CEO Biotech companies are 'growing exponentially Flipboard

Charles River Laboratories Completes Acquisition of Vigene Biosciences WILMINGTON, Mass.-- ( Based in Rockville, Maryland, Vigene Biosciences is a premier, gene therapy contract development and.

Charles River Laboratories expanding Memphis CDMO biotech facility Memphis Business Journal

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the.

Charles River Laboratories ‘weathers COVID challenges’ to see healthy growth Biotech Today

Charles River Laboratories x Buckeye Biotech Meeting Slides Buckeye Biotechnology Association

The Charles River Biotech Symposium unites drug development professionals in an interactive setting to discuss the nonclinical development of biotherapeutics, including regulatory issues and innovative approaches to problem solving. The collegial spirit of this meeting creates exceptional opportunities for information sharing and networking.

Charles River Associates buys BioStrategies Group — Consulting Point

In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy. Cognate, along with gene therapy CDMO providers Cobra Biologics and Vigene Biosciences , join Charles River to offer customers a single, trusted partner who has the insight and.

Charles River in Reno big part of biotech industry boom Serving Northern Nevada

Charles River Labs to buy Memphis biotech R&D firm for 875M Origin Staffing

Charles River Laboratories has strengthened its high-throughput screening capabilities (HTS) by gaining access to technologies available at AstraZeneca's Centre for Lead Discovery in Cambridge, U.K.

Why Charles River Labs is the Biotech stock to buy Jim Cramer Charles River

Charles River Forms Drug Discovery Pact with CNSFocused Biotech Charles River

Cell & Gene Therapy Vaccine By Research Phase Toggle menu Basic Research Discovery Preclinical Testing Clinical Development Manufacturing & Commercialization BY Therapeutic Area Toggle menu COVID-19 Cardiovascular Disease Immunology Infectious Disease Inflammation Metabolic Disease Microbiome Research Musculoskeletal Disease Neuroscience Oncology

Charles River Biotech Symposium BiotechnologyDerived Therapeutics Perspectives on Nonclinical

Charles River supplies and manages study-ready, preconditioned and genetically engineered animal models and services to support today's most critical research. Pharmaceutical and Biotechnology companies around the globe depend on our extensive portfolio of models to study disease in critical therapeutic areas.